drugset / Trial / NCT00772564
The Use of Statins for Myocardial Death Prevention
RandomizedParallel-groupOpen-labelPrevention
Summary
The administration of high dose HMG-CoA reductase inhibitors (Statins) to patients with acute ST-elevation MI (hypoxia/ischemia) who are treated with primary PCI (reoxygenation/ reperfusion) will protect their cardiomyocytes from death and thus preserve LV ejection fraction.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-06
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | Oral |
| Subject | Atorvastatin | Small molecule | 80 mg | Oral |